Kairos Pharma Wins DoD Grant to Study ENV105 for Drug-Resistant Lung Cancer
Kairos Pharma Wins DoD Grant to Study ENV105 for Drug-Resistant Lung Cancer Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has announced a major…
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D.
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D. EnPlusOne Biosciences, Inc., a trailblazing biotechnology company pioneering enzyme-driven RNA synthesis technologies, announced today the appointment of Clare Murray, Ph.D., as its…
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P,…
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery PharmaJet, a medical technology company pioneering innovative approaches to injectable drug delivery, will unveil compelling new data from…
Rigaku Partners with Spera Pharma to Advance Drug Development
Rigaku Partners with Spera Pharma to Advance Drug Development In a move poised to reshape the landscape of drug discovery and pharmaceutical development, Rigaku Corporation—a leading scientific instrumentation manufacturer—and SPERA…
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG Glycomine, Inc., a clinical-stage biotechnology company dedicated to developing life-changing therapies for patients suffering from orphan…
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer EveryONE Medicines, a trailblazing biotech company transforming the way individualized therapies are developed for children suffering from ultra-rare…
Aptar Launches Study to Speed FDA Approval of SmartTrack™ Platform for Inhalers
Aptar Launches Study to Speed FDA Approval of SmartTrack™ Platform for Inhalers AptarGroup, Inc., a global leader in drug delivery and consumer product dispensing systems, has announced a pivotal step…
Flatiron Health Partners with Veeva to Advance Oncology Research
Flatiron Health Partners with Veeva to Advance Oncology Research In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical…
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville PursueCare, a leader in virtual addiction treatment and medication-assisted therapy, is pleased to announce its participation in the 2025…
Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions
Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions In a significant advancement for the field of neurodegenerative disease management, Octave Bioscience, Inc., a precision care…
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59 Pfizer Inc. (NYSE: PFE) has taken a significant step forward in the effort to combat respiratory syncytial virus (RSV)…